Funding Support (Active)
7. Point-of-care optical spectroscopy platform and novel ratio-metric algorithms for rapid and systematic functional characterization of biological models in vivo
Funding source: NIDCR R01; Role: PI; (Aug 1 2023- July 31 2028)
6. Non-destructive optical spectroscopic assay for high-throughput metabolic characterization of in vitro cell models and patient-derived organoids
Funding source: NIBIB Trailblazer R21; Role: PI; (Aug 1 2022 - March 31 2025)
Funding Support (Completed)
5. Optical metabolic microscope to study breast cancer radiation biology.
Funding source: ACS-IRG; Role: PI; (Dec 1 2022 - Nov30 2023)
4. Optical spectroscopy and microscopy development for translational cancer research.
Funding source: University of Kentucky Startup; Role: PI; (Aug 1 2019- June 30 2024)
3. Optical metabolic imaging on live tumor slices to predict tumor therapy responses.
Funding source: University of Kentucky Markey Cancer Center; Role: PI; (July 1 2022 - June 30 2023)
2. Intra-vital metabolic microscopy to reveal human cancer radiation resistance mechanism in small animal models
Funding source: NIH/NIGMS; Role: COBRE project leader PI; (Oct 1 2019 - Dec 31 2022)
1. Early prediction of radiation responses for breast cancer patients during the BCS
Funding source: University of Kentucky IRC; Role: PI; (Jan 1 2021 - Dec 31 2021)